Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Can moving needles ease Crash-Related shoulder pain?

NCT ID NCT07187336

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Aug 06, 2026 · Updated 2 times

Summary

This study tests a type of acupuncture called Motion Style Acupuncture Treatment (MSAT) for shoulder pain caused by traffic accidents. About 98 adults with acute shoulder pain will be randomly assigned to receive either standard Korean medicine alone or standard care plus MSAT. The goal is to see if adding MSAT improves pain, movement, and daily function better than standard care alone.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 98 people

The number the study aims to enrol. It can still change while the study runs.

Started

Nov 2025

Expected to finish

Aug 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

19 to 70 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: Adults aged 19 to 70 years Hospitalized with shoulder pain within 5 days after a traffic accident Shoulder pain intensity ≥ 5 on the Numeric Rating Scale (NRS) with observed limitation of movement Able and willing to provide written informed consent Exclusion Criteria: Serious conditions causing shoulder pain (e.g., malignant tumor, infection) Progressive or severe neurological deficits Recent shoulder surgery or procedure within 3 weeks Shoulder pain mainly due to non-shoulder disorders (e.g., fibromyalgia, rheumatoid arthritis, gout) Contraindications to MSAT (e.g., fracture, dislocation, ligament rupture or instability, severe inflammation) Chronic diseases interfering with assessment (e.g., cardiovascular disease, renal disease, diabetic neuropathy, dementia, epilepsy) Current use of steroids, immunosuppressants, psychiatric drugs, or other medications that may affect results Contraindications to acupuncture (e.g., bleeding disorders, anticoagulant use, severe diabetes, severe cardiovascular disease) Pregnant or planning pregnancy Severe psychiatric illness Participation in another interventional clinical trial Unable to provide informed consent Any other condition deemed inappropriate by the investigator

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Shoulder pain are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Shoulder Pain

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Haeundae Jaseng Hospital of Korean Medicine

    Busan, Haeundae, 48102, South Korea

More trials for these conditions

Other studies related to the condition(s) this trial covers.